Latest for Paraganglioma
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Label changeThe FDA approved a label update for WeliregFDA
More about Paraganglioma
Other inherited causes include changes in the VHL, RET, NF1, TMEM127, MAX and FH genes. Paragangliomas in the head and neck usually make no catecholamines, according to the National Cancer Institute, while many in the chest, belly and pelvis do, presenting with hypertension, palpitations, panic attacks, and severe hyperadrenergic symptoms. Non-secreting tumors present with mass effects or are discovered incidentally on imaging. Critically, about 30-40% of paragangliomas have malignant potential with metastatic disease. Location, tumor size, rapid growth, and SDH mutation status (particularly SDHB) help predict malignant behavior.
Keep reading about Paraganglioma
Diagnosis combines biochemical testing (plasma metanephrines, 24-hour urinary catecholamines), imaging (CT, MRI, PET), and genetic testing. Histology shows nests of polygonal neuroendocrine cells separated by vascular fibrous septa.
What are the symptoms of Paraganglioma?
These are common symptoms of Paraganglioma, and how strong they are varies from person to person.
- Hypertension and hypertensive episodes
- Palpitations and tachycardia
- Diaphoresis and flushing
- Headaches and chest/abdominal pain
- Metastatic disease in malignant forms
- Variable hormone excess manifestations
Who gets Paraganglioma?
Can present at any age but hereditary forms often manifest in 30s-50s with peak in third and fourth decades. Sporadic tumors typically present later in adulthood. Affects males and females approximately equally in most series, with some male predominance reported.
Hereditary paraganglioma syndromes (PGL1-5) show autosomal dominant inheritance with variable penetrance. SDHB mutations, most commonly associated with malignancy, show higher penetrance and earlier presentation. Higher prevalence reported in Nordic, Eastern European, and certain other populations.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Paraganglioma?
There is currently 1 FDA-approved medication for Paraganglioma.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Paraganglioma treatment
Charity funds and drugmaker programs for Paraganglioma, checked at the source.
No charity fund for this condition is open right now. Funds reopen when they receive new donations; the foundations let you sign up to be told when one opens.
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Paraganglioma
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Paraganglioma resources
Reputable organizations and medical references for learning more about Paraganglioma, including disease registries, foundation resources, and clinical guidelines.